Monoclonal therapeutics and diagnostic antibodies market worth $56 billion by 2012
The monoclonal therapeutic and diagnostic antibodies market is expected to increase by 80% by 2012, according to a technical market research report by BCC Research.
Titled Monoclonal Therapeutics and Diagnostic Imaging Products: The Global Market (Bio016g), the report showed the global market for monoclonal therapeutic and diagnostic antibodies was worth $31 billion in 2007. This is expected to increase to over $56 billion by 2012, a compound average annual growth rate (CAGR) of 13%.
For more information on the report, visit www.bccresearch.com.
Antibody treatment reprograms immune system after heart attack
A new drug being trialled in heart attack patients could reprogram the immune system to prevent...
Nanoparticles supercharge vinegar's wound-healing power
Adding microscopic particles to vinegar can make them more effective against dangerous bacterial...
Not all brown snake venoms are alike, causing antivenom concerns
Venom from northern and southern populations of eastern brown snake builds blood clots in very...
